Evaluate the efficacy and safety of Doxorubicin Hydrochloride Liposome Injection Plus
Cyclophosphamide Compared to Pirarubicin Plus Cyclophosphamide as Neoadjuvant Chemotherapy in
Locally Advanced Breast Cancer Patients
Drug: Doxorubicin Hydrochloride Liposome injection and cyclophosphamide
Drug: pirarubicin and cyclophosphamide
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT02903524
Ages eligible for Study
18 Years to 70 Years
Genders eligible for Study
Accepts Healthy Volunteers
Female patients with age between 18 and 70 years.
Newly diagnosed breast cancer, stages IIb-IIIc.
KPS performance status≥70.
Measurable disease according to RECIST version 1.1.
Normal cardiac function confirmed by baseline left ventricular ejection fraction
Adequate bone marrow reserve (WBC≥4.0×10(9)/L, neutrophils≥2.0×10(9)/L, platelets≥100×10(9)/L,and hemoglobin≥90g/L).
Adequate hepatic and renal function.
AST and ALT ≤ 2×institutional upper limit of normal；alkaline phosphatase ≤ 2×institutional upper limit of normal；bilirubin ≤ institutional upper limit of normal.
Serum creatinine≥44 µmol/L and ≤133 µmol/L.
Written informed consent are acquired.
Not in pregnancy or the pregnancy tests of females is negative.
Severe heart failure (NYHA grade II or higher).
Active and uncontrolled severe infection.
Have accepted any other anti-tumor drug within 30 days before the first dose or
received radiation treatment.
Other situations that investigators consider as contra-indication for this study.
All locations for NCT02903524
Fourth Hospital of Hebei Medical University
Shi Jiazhuang, Hebei, China, 050019
Put me in touch!
View full eligibility
Tris trial is registered with FDA with number: NCT02903524. The sponsor of the trial is Hebei Medical University Fourth Hospital and it is looking for 300 volunteers for the current phase.
Official trial title: The Efficacy and Safety of Doxorubicin Hydrochloride Liposome Injection Plus Cyclophosphamide Compared to Pirarubicin Plus Cyclophosphamide as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer ：a Randomised Multicentre, Open-label Trial
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Thank you for applying!
We'll contact you soon with more information.
Consult your doctor?
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.